Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension

Blood Pressure

Volumn 23, Issue 3, 2014, Pages 147-153

  Di Chiara, Tiziana ^a   Licata, Anna ^a   Argano, Christiano ^a   Duro, Giovanni ^b   Corrao, Salvatore ^a   Scaglione, Rosario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

Author keywords

Adiponectin; Left ventricular mass; Obesity associated hypertension

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ABDOMINAL OBESITY; AGED; BLOOD; CARDIOVASCULAR DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; MIDDLE AGED; PROCEDURES;

ADIPONECTIN; AGED; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL;

EID: 84901024705     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2013.823767     Document Type: Article

References (36)

1. The Task force for the management of arterial hypertension of the European Society of Hypertension (ESC) and of the European Society of Cardiology (ESC). 2007 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2007; 28: 1462-1536
2. Nguyen T, Lau D CW. The obesity epidemic and its impact on hypertension. Canad J Cardiol. 2012; 28: 326-333
3. Licata G, Scaglione R, Barbagallo M, Parrinello G, Capuana G, Lipari R, et al. Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obesity. 1991; 15: 295-302
4. Licata G, Scaglione R, Capuana G, Parrinello G, Di Vincenzo D, Mazzola G. Hypertension in obese subjects: A distincThypertensive subgroup. J Hum Hypertens. 1990; 4: 37-41. (Pubitemid 20071244
5. Scaglione R, Di Chiara MA, Indovina A, Lipari R, Ganguzza A, Parrinello G, et al. Left ventricular diastolic and systolic function in normotensive obese subjects: Infl uence of degree and duration of obesity. Eur Heart J. 1992; 13: 738-742
6. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, et al. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity and diastolic blood pressure in young obese subjects. Am J Hypertens. 1994; 7: 314-320. (Pubitemid 24138016
7. De Simone G, Kizer J R, Chinali M, Roman M J, Bella J N, Best LG, et al. Normalization for body size and populationattributable risk of left ventricular hypertrophy: The Strong Heart Study. Am J Hypertens. 2005; 18: 191-196. (Pubitemid 40332548
8. Licata G, Scaglione R, Corrao S, Ganguzza A, Mazzola G, Arnone S, et al. Heredity and obesity-Associated hypertension: Impact on hormonal characteristics and left ventricular mass. J Hypertens. 1995, 13: 611-618
9. Parrinello G, Licata A, Colomba D, Di Chiara T, Argano C, Bologna P, et al. Left ventricular fi lling abnormalities and obesity associated hypertension: Relationship with overproduction of circulating transforming growth factor beta1. J Hum Hypertens. 2005; 19: 543-550. (Pubitemid 40946039
10. Scaglione R, Di Chiara T, Cariello T, Licata G. V isceral obesity and metabolic syndrome: Two faces of the same medal?. Intern Emerg Med. 2010; 5: 111-119
11. Nishida M, Funahashi T, Shimomura I. P athophysiological signifi cance of adiponectin. Med Mol Morphol. 2007; 40: 55-67
12. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291: 134-141
13. Kojima S, Funahashi T, Maruyoshi H, Honda O, Sugiyama S, Kavano H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with ateroma. Thromb Res. 2005; 115: 483-490. (Pubitemid 40409981
14. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004; 90: 528-533. (Pubitemid 38530170
15. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS. 2006; 580: 2917-2921
16. Diez JJ, Iglesias P. The role of novel adipocyte-derived hormone adiponectin in human Disease. Eur J Endocrinol. 2003; 148: 293-300. (Pubitemid 36410714
17. Di Chiara T, Argano C, Corrao S, Scaglione R, Licata G. Hypoadiponectinemia: A link between visceral obesity and metabolic syndrome. J Nutr Metab. 2012; ID175245: 1-7
18. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004; 10: 1384-1389. (Pubitemid 40022722
19. Mitsuhashi H, Yatsuya H, Tamakowshi K, Matsushita K, Otsuka R, Wada K, et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension. 2007; 49: 1448-1454. (Pubitemid 46809393
20. Crepaldi G, Belfi ore F, Bosello O, Caviezel F, Contaldo F, Enzi G, Melchionda N. Special report: Italian Consensus Conference-Overweight, Obesity and Health. Int J Obesity. 1991; 15: 781-790
21. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, et al. Central obesity and hypertension: Pathophysiologic role of renal haemodynamics and function. Int J Obesity. 1995; 19: 403-409
22. Pischon T, Hotamisligil GS, Rimm EB. A diponectin: Stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem. 2003; 49: 650-652. (Pubitemid 36379531
23. Corrao S, Parrinello G, Arnone S, Indovina A, Scaglione R, Licata G. Infl uence of obesity on the echocardiographic evaluation of left ventricular ejection fraction by arealength method: Comparison with radionuclide angiography. J Cardiovasc Diagn Proced. 1993; 11: 127-134. (Pubitemid 24067335
24. Schillaci G, Pirro M. Hypoadiponectinemia: A novel link between obesity and hypertension?. Hypertension. 2007; 49: 1217-1229
25. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003; 16: 72-75. (Pubitemid 36078595
26. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004; 43: 1318-1323. (Pubitemid 38691756
27. Chow WS, Cheung BM, Tso A W, Xu A, Wat NM, Fong CH, et al. Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension. 2007; 49: 1455-1461
28. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesityrelated hypertension. Hypertension. 2006; 47: 1108-1116. (Pubitemid 44289168
29. ShunkerTh. O besity and target organ Damage: The heart. Int J Obesity. 2002; 26 Suppl 4: S15-S20
30. Vasan R S. C ardiac function and obesity. H eart. 2 003; 8 9: 1127-1129
31. Theckbert S R, Post W, Pearson G D, Arnett D K, Gomes AS, Jerosch-Herold M, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: The Multiethnic Study of Atherosclerosis. J Am Coll Cardiol. 2006; 48: 2285-2292. (Pubitemid 44855426
32. Wong CY, O M oore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004; 110: 3081-3087
33. Ybarra J, Resmini E, Planas F, Navarro-Lopez F, Webb S, Pou JM, et al. Relationship between adiponectin and left atrium size in uncomplicated obese patients: Adiponectin, alink between fat and heart. Obes Surg. 2009; 19: 1324-1332
34. Katagiri H, Yamada T, Oka Y. A diposity and cardiovascular disorders: Disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007; 101: 27-39. (Pubitemid 47094621
35. Thong SJ, Park CG, Seo HS, Oh DJ, Ro YM. A ssociations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 2004; 13: 236-242. (Pubitemid 39248187
36. Lindberg S, Mogelvang R, Pedersen SH, Bjerre M, Frystyk J, Flyvbjerg A et al. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol. 2013; 111: 1139-1145